Cathal Crowe
Ceist:733. Deputy Cathal Crowe asked the Minister for Health in respect of the treatment abroad scheme, the person or body within the HSE decides if a product is experimental; the criteria this decision maker uses to decide such and the definitions applied to experimental treatment; if the relevant decision makers have the expertise to review drugs for complex conditions; if the existing reimbursement list is referred to in making reimbursement decisions or whether EMA approval is deemed to be the over-riding proof of clinical safety; and if he will make a statement on the matter. [39088/22]
Amharc ar fhreagra